These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3791781)

  • 1. Cardiac gallium uptake in doxorubicin-induced cardiotoxicity.
    Hatfield MK; Martin WB; Ryan JW; Vokes EE; Vogelzang NJ
    Clin Nucl Med; 1986 Nov; 11(11):756-7. PubMed ID: 3791781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gallium-67 myocardial imaging for the detection of adriamycin cardiomyopathy].
    Morozumi T; Ishida Y; Tani A; Inui M; Hori M; Kitabatake A; Kamada T; Kondo H; Kozuka T; Kimura K
    Kaku Igaku; 1990 May; 27(5):477-84. PubMed ID: 2395231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimyosin positivity in doxorubicin cardiotoxicity: earlier than the conventional evidence.
    Narula J; Strauss HW; Khaw BA
    J Nucl Med; 1993 Sep; 34(9):1507-9. PubMed ID: 8355071
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity.
    Steinberg JS; Wasserman AG
    Clin Ther; 1985; 7(6):660-7. PubMed ID: 3907840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective right ventricular dysfunction following doxorubicin therapy.
    Sperber AD; Cantor AA; Biran H; Keynan A
    Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionucleotide ejection fraction and prediction of doxorubicin cardiotoxicity.
    Morgan GW; Choy D; Freedman A
    Lancet; 1978 Jun; 1(8077):1315-6. PubMed ID: 78081
    [No Abstract]   [Full Text] [Related]  

  • 9. Late doxorubicin cardiotoxicity.
    Lishner M; Elis A; Ravid M
    Anticancer Drugs; 1992 Aug; 3(4):367-9. PubMed ID: 1421431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymucositis: a cause of Ga-67 uptake.
    Sty JR; Starshak RJ; Lauer SJ
    Clin Nucl Med; 1981 Mar; 6(3):126. PubMed ID: 7460459
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity.
    McKillop JH; Bristow MR; Goris ML; Billingham ME; Bockemuehl K
    Am Heart J; 1983 Nov; 106(5 Pt 1):1048-56. PubMed ID: 6637763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible doxorubicin-induced congestive heart failure.
    Cohen M; Kronzon I; Lebowitz A
    Arch Intern Med; 1982 Aug; 142(8):1570-1. PubMed ID: 7103641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive cardiac Ga-67 uptake in a child with pulmonary hypertension, heart failure, and bleeding.
    Karimeddini MK; Serpa MA; Spencer RP
    Clin Nucl Med; 1997 Feb; 22(2):128-9. PubMed ID: 9031777
    [No Abstract]   [Full Text] [Related]  

  • 15. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
    Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
    Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin, congestive cardiomyopathy, and metaiodobenzylguanidine.
    Strashun A
    J Nucl Med; 1992 Feb; 33(2):215-22. PubMed ID: 1732443
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?
    Jain D; Zaret BL
    J Nucl Med; 1990 Dec; 31(12):1970-4. PubMed ID: 2266395
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and significance of gallium-67 uptake in the heart after open-heart surgery.
    Huikuri HV; Ikäheimo MJ; Airaksinen J; Linnaluoto MM; Heikkilä J; Takkunen JT
    Am J Cardiol; 1988 Feb; 61(4):405-8. PubMed ID: 3341221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cardiac failure from doxorubicin cardiotoxicity provoked in relation to second-look laparotomy.
    Aabo K; Mortensen SA; Jonsson T; Hansen HH
    Cancer Treat Rep; 1985 Jun; 69(6):730-1. PubMed ID: 4016780
    [No Abstract]   [Full Text] [Related]  

  • 20. Gallium-67 uptake in silent myocardial infarction: a case report.
    Schor RA; Massie BM; Botvinick EH; Shames DM
    Radiology; 1978 Oct; 129(1):117-8. PubMed ID: 693859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.